Akèy › Dyare
Etid klinik pou Dyare ap rekrite nan Etazini
9 etid pou Dyare ap rekrite patisipan nan sit atravè Etazini.
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07545759Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04038619Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Ap rekriteFaz 4
Laj 6 a 12 · Tout sèks · Mizajou Aug 13, 2026 · NCT07285785Rash & Diarrhea Prophylaxis With Capivasertib
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT07426822A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT06801067Fecal Microbiota Transplantation for IBS
Ap rekriteFaz 2
Laj 18 a 70 · Fanm · Mizajou May 8, 2026 · NCT05776914Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator
Ap rekriteFaz 1 bonè
Laj 18 a 70 · Tout sèks · Mizajou Dec 18, 2025 · NCT06684470First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 49 · Tout sèks · Mizajou Nov 19, 2025 · NCT07205926Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions
Ap rekrite
Laj 25 a 75 · Tout sèks · Mizajou Jan 29, 2025 · NCT05465629Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.